Category - New Drugs
FDA Approves Accrufer (ferric maltol) for the Treatment of Iron Deficiency in Adults
FDA Approves Baqsimi (glucagon) Nasal Powder for the Treatment of Severe Hypoglycemia
FDA Approves Hadlima (adalimumab-bwwd), a Biosimilar to Humira
FDA Approves Ruxience (rituximab-pvvr), a Biosimilar to Rituxan
Baxter Announces U.S FDA Approval of Myxredlin, the First and Only Ready-To-Use Insulin for IV Infusion
FDA Approves Otezla (apremilast) for the Treatment of Oral Ulcers Associated with Behçet’s Disease
FDA Approves Recarbrio (imipenem, cilastatin, and relebactam) for the Treatment of Complicated Urinary Tract and Complicated Intra-Abdominal Bacterial Infections
FDA Approves AirDuo Digihaler (fluticasone propionate and salmeterol) Inhalation Powder for Asthma